Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/30/24
End: 07/13/26
Due: 07/13/27
Phase: N/A
Priority: Normal
Start: 04/12/23
End: 01/01/26
Due: 01/01/27
Phase: N/A
Priority: Normal
Start: 01/18/23
End: 01/18/29
Due: 01/18/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma | NCT06734871 | Aibin Liang，MD，Ph.D. | user2@example.com | None | 2024-12-30 | 2026-07-13 | 2027-07-13 | - | - | 2025-07-14 |
| Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia | NCT05893693 | Aibin Liang，MD，Ph.D. | user2@example.com | None | 2023-04-12 | 2026-01-01 | 2027-01-01 | - | - | 2025-07-14 |
| Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma | NCT05842707 | Aibin Liang，MD，Ph.D. | user2@example.com | None | 2023-01-18 | 2029-01-18 | 2030-01-18 | - | - | 2025-07-14 |